Penulis: Richard C. Zink

Richard C. Zink, Ph D, is Principal Research Statistician Developer in the JMP Life Sciences division at SAS Institute. He is currently a developer for JMP Clinical, an innovative software package designed to streamline the review of clinical trial data. He joined SAS in 2011 after eight years in the pharmaceutical industry. He is an active member of the Biopharmaceutical Section of the American Statistical Association (ASA), serving as industry co-chair for the 2015 ASA Biopharmaceutical Section Statistics Workshop, and as a member of the Safety Scientific Working Group. He is a member of the Drug Information Association where he serves as Statistics Section Editor for Therapeutic Innovation & Regulatory Science. Richard is a member of Statisticians in the Pharmaceutical Industry, and holds a Ph D in Biostatistics from the University of North Carolina at Chapel Hill, where he serves as an adjunct faculty member. He is author of Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS.